Innovation1 Biotech Inc.
Innovation1 Biotech Inc. (IVBT) Revenue
Annual & quarterly revenue history · segment & region breakdown
IVBT · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsInnovation1 Biotech Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2023.
Revenue trend
2023 – 2015 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2023-08-31 | $0.00B | +$0.00B | — |
| 2022-08-31 | $0.00B | -$0.00B | -100.00% |
| 2021-08-31 | $0.00B | +$0.00B | +160.80% |
| 2020-08-31 | $0.00B | -$0.00B | -98.51% |
| 2019-08-31 | $0.00B | +$0.00B | +372.52% |
| 2018-08-31 | $0.00B | +$0.00B | — |
| 2017-08-31 | $0.00B | +$0.00B | — |
| 2016-08-31 | $0.00B | +$0.00B | — |
| 2015-08-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Innovation1 Biotech Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Innovation1 Biotech Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Innovation1 Biotech Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
IVBT revenue · 4 questionsIVBT's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2023.
▸ Source: FMP · Innovation1 Biotech Inc. SEC filings · GAAP · Innovation1 Biotech Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026